23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.91%
Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-4.91%
Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
3.35%
EBIT growth exceeding 1.5x Insurance - Life median of 1.43%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
3.35%
Operating income growth 1.25-1.5x Insurance - Life median of 2.75%. Mohnish Pabrai would confirm if scale economies are a factor.
1.40%
Net income growth exceeding 1.5x Insurance - Life median of 0.01%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
1.39%
EPS growth of 1.39% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
1.41%
Diluted EPS growth of 1.41% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.52%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-13.52%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
16.96%
10Y CAGR of 16.96% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
16.96%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 0.49%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
15.48%
3Y revenue/share growth near Insurance - Life median of 15.48%. Charlie Munger would note typical industry expansions over the short term.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
63.23%
3Y OCF/share growth > 1.5x Insurance - Life median of 12.66%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
75.60%
Net income/share CAGR of 75.60% while Insurance - Life median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
75.60%
5Y net income/share CAGR > 1.5x Insurance - Life median of 15.43%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
24.71%
3Y net income/share CAGR near Insurance - Life median. Charlie Munger sees standard sector-level performance in the last few years.
38.70%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 4.51% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
38.70%
5Y equity/share CAGR > 1.5x Insurance - Life median of 1.58%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
28.10%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.30%
Asset growth near Insurance - Life median. Charlie Munger attributes it to a typical industry cycle of capital investment.
1.98%
BV/share growth of 1.98% while Insurance - Life is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-0.78%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-4.95%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.